ArticleCancers2022

LAG3-PD1 or CTLA4-PD1 Inhibition in Advanced Melanoma: Indirect Cross Comparisons of the CheckMate-067 and RELATIVITY-047 Trials.

Bai-Wei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.